Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Removing Ineffective Drugs From the Market — Sarah Tanveer (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Removing Ineffective Drugs From the Market
Shared by
John P A Ioannidis
Stanford University
Removing Ineffective Drugs From the Market
Article
2025
en
Authors
ST
Sarah Tanveer
John P A Ioannidis
Stanford University
Abstract
1 min read
This Viewpoint examines the removal of ineffective licensed products from the market, specifically discussing the example of oral phenylephrine.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2021
Roles of retailers in the peer-to-peer electricity market: A single retailer perspective
Wayes Tushar
,
Chau Yuen
,
Tapan Kumar Saha
,
Deb Chattopadhyay
,
Mohammad Sohrab Hasan Nizami
,
Sarmad Hanif
,
Jan E. Alam
,
H Vincent Vincent Poort
Preprint
2021
Roles of Retailers in the Peer-to-Peer Electricity Market: A Single Retailer Perspective
Wayes Tushar
,
Chau Yuen
,
Tapan Kumar Saha
,
Deb Chattopadhyay
,
Mohammad Sohrab Hasan Nizami
,
Sarmad Hanif
,
Jan E. Alam
,
H Vincent Vincent Poort
Preprint
2021
Roles of Retailers in the Peer-to-Peer Electricity Market: A Single\n Retailer Perspective
Wayes Tushar
,
Chau Yuen
,
Tapan Kumar Saha
,
Deb Chattopadhyay
,
Mohammad Sohrab Hasan Nizami
,
Sarmad Hanif
,
Jan E. Alam
,
H Vincent Vincent Poort
Article
2023
Pretrained transformer models for predicting the withdrawal of drugs from the market
Eyal Mazuz
,
Guy Shtar
,
Nir Kutsky
,
Lior Rokach
,
Bracha Shapira
Bioinformatics
Article
2013
Cost and potential of carbon abatement from the UK perennial energy crop market
Peter Alexander
,
Dominic Moran
,
Mark Rounsevell
,
Jonathan Hillier
,
Pete Smith
Discussion(0)
No comments yet. Be the first to comment.